List of works - David Ho

A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike

scientific article published on 04 July 2020

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

scientific article published on 8 March 2021

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

scientific article

Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains

scientific article published on 17 November 2020

Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas

scientific article published on 21 April 2015

Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design

scientific article

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

scientific article published on September 2010

Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike

scientific article published on 18 June 2020

Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles

scientific article

Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles

scientific article published on 13 September 2020

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

scientific article

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

scientific article published on 23 June 2020

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

scientific article published on 21 July 2020

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes ⬇️

scientific article published on 12 October 2020

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1

scientific article published on 21 September 2015

Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide

scientific article published on 15 December 2020

List of works by David Ho

A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains

Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas

Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike

Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles

Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes ⬇️

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1

Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide